Endocyte (ECYT) Removed from Wedbush's Best Ideas List
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Baird Downgrades Endocyte (ECYT) to Neutral
May 2, 2014 10:17 AM EDTBaird downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral with a price target of $8.00.
For an analyst ratings summary and ratings history on Endocyte click here. For more ratings news on Endocyte click here.
Shares of Endocyte closed at $17.38 yesterday.
... MorePiper Jaffray Downgrades Endocyte (ECYT) to Neutral
May 2, 2014 9:03 AM EDTPiper Jaffray downgraded Endocyte (NASDAQ: ECYT) from Overweight to Neutral with a price target of $13.50.
For an analyst ratings summary and ratings history on Endocyte click here. For more ratings news on Endocyte click here.
Shares of Endocyte closed at $17.38 yesterday.
... MoreEndocyte, Inc. (ECYT) Tops Q1 EPS by 5c; Reports Halt of PROCEED Trial (MRK)
May 2, 2014 8:02 AM EDTEndocyte, Inc. (NASDAQ: ECYT) reported Q1 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $17.3 million versus the consensus estimate of $15.07 million.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and... More
Endocyte, Inc. (ECYT) trading halted with news pending
May 2, 2014 7:57 AM EDTEndocyte, Inc. (NASDAQ: ECYT) trading halted with news pending.
... More